Lentiviral vector-mediated siRNA knockdown of the YAP gene inhibits growth and induces apoptosis in the SGC7901 gastric cancer cell line

Molecular Medicine Reports

Volumn 4, Issue 6, 2011, Pages 1075-1082

  Zhou, Zhou ^a   Zhu, Jin Shui ^a   Xu, Zhi Peng ^a   Zhang, Qiang ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Cell apoptosis; Cell proliferation; RNA interference; YAP gene

Indexed keywords

ALPHA FETOPROTEIN; CYCLIN A; CYCLIN D1; CYCLIN E; CYCLINE; KI 67 ANTIGEN; LENTIVIRUS VECTOR; MESSENGER RNA; SHORT HAIRPIN RNA; SMALL INTERFERING RNA; SURVIVIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; YES ASSOCIATED PROTEIN;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL GROWTH; CELL POPULATION; CELL PROLIFERATION; DOWN REGULATION; GENE EXPRESSION; GENE SEQUENCE; GENE SILENCING; GENETIC CODE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LENTIVIRINAE; REAL TIME POLYMERASE CHAIN REACTION; STOMACH CANCER; STOMACH CARCINOMA; WESTERN BLOTTING;

APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLIN D1; G0 PHASE; G1 PHASE; GENETIC VECTORS; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; KI-67 ANTIGEN; LENTIVIRUS; NUCLEAR PROTEINS; PROLIFERATING CELL NUCLEAR ANTIGEN; RNA INTERFERENCE; RNA, SMALL INTERFERING; STOMACH NEOPLASMS; TRANSCRIPTION FACTORS;

LENTIVIRUS;

EID: 80053127617     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2011.543     Document Type: Article

References (35)

1. Guo HQ, Guan P, Shi HL, Zhang X, Zhou BS and Yuan Y: Prospective cohort study of comprehensive prevention to gastric cancer. World J Gastroenterol 9: 432-436, 2003. (Pubitemid 36372101)
2. Dong J, Feldmann G, Huang J, et al: Elucidation of a universal size-control mechanism in Drosophila and mammals. Cell 130: 1120-1133, 2007. (Pubitemid 47410268)
3. Overholtzer M, Zhang J, Smolen GA, et al: Transforming properties of YAP, a candidate oncogene on the chromosome 11q22 amplicon. Proc Natl Acad Sci USA 103: 12405-12410, 2006. (Pubitemid 44267272)
4. Zender L, Spector MS, Xue W, et al: Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach. Cell 125: 1253-1267, 2006. (Pubitemid 43929093)
5. Steinhardt AA, Gayyed MF, Klein AP, et al: Expression of Yes-associated protein in common solid tumors. Hum Pathol 39: 1582-1589, 2008.
6. Paddison PJ, Caudy AA, Bernstein E, Hannon GJ and Conklin DS: Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells. Genes Dev 16: 948-958, 2002. (Pubitemid 34408544)
7. Crombie C and Fraser A: Treating genetic disease through RNA interference. Lancet 365: 1288-1290, 2005.
8. Lam-Himlin DM, Daniels JA, Gayyed MF, et al: The hippo pathway in human upper gastrointestinal dysplasia and carcinoma: a novel oncogenic pathway. Int J Gastrointest Cancer 37: 103-109, 2006. (Pubitemid 351642210)
9. Qiu Z, Huang C, Sun J, et al: RNA interference-mediated signal transducers and activators of transcription 3 gene silencing inhibits invasion and metastasis of human pancreatic cancer cells. Cancer Sci 98: 1099-1106, 2007. (Pubitemid 46865397)
10. Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408, 2001. (Pubitemid 34164012)
11. Hanahan D and Weinberg RA: The hallmarks of cancer. Cell 100: 57-70, 2000. (Pubitemid 30046295)
12. Sherr CJ and Roberts JM: CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev 13: 1501-1512, 1999. (Pubitemid 29297917)
13. Pan D: Hippo signaling in organ size control. Genes Dev 21: 886-897, 2007.
14. Edgar BA: From cell structure to transcription: Hippo forges a new path. Cell 124: 267-273, 2006.
15. Harvey K and Tapon N: The Salvador-Warts-Hippo pathway - an emerging tumour-suppressor network. Nat Rev Cancer 7: 182-191, 2007.
16. Zhao B, Lei QY and Guan KL: The Hippo-YAP pathway: new connections between regulation of organ size and cancer. Curr Opin Cell Biol 20: 638-646, 2008.
17. Kango-Singh M and Singh A: Regulation of organ size: insights from the Drosophila Hippo signaling pathway. Dev Dyn 238: 1627-1637, 2009.
18. Huang J, Wu S, Barrera J, Matthews K and Pan D: The Hippo signaling pathway coordinately regulates cell proliferation and apoptosis by inactivating Yorkie, the Drosophila Homolog of YAP. Cell 122: 421-434, 2005. (Pubitemid 41127143)
19. Basu S, Totty NF, Irwin MS, Sudol M and Downward J: Akt phosphorylates the Yes-associated protein, YAP, to induce interaction with 14-3-3 and attenuation of p73-mediated apoptosis. Mol Cell 11: 11-23, 2003. (Pubitemid 36126587)
20. Strano S, Munarriz E, Rossi M, et al: Physical interaction with Yes-associated protein enhances p73 transcriptional activity. J Biol Chem 276: 15164-15173, 2001.
21. Zhang J, Ji JY, Yu M, et al: YAP-dependent induction of amphiregulin identifies a non-cell-autonomous component of the Hippo pathway. Nat Cell Biol 11: 1444-1450, 2009.
22. Ferrigno O, Lallemand F, Verrecchia F, L'Hoste S, Camonis J, Atfi A and Mauviel A Yes-associated protein (YAP65) interacts with Smad7 and potentiates its inhibitory activity against TGF-beta/Smad signaling. Oncogene 21: 4879-4884, 2002.
23. Yagi R, Chen LF, Shigesada K, Murakami Y and Ito Y: A WW domain-containing yes-associated protein (YAP) is a novel transcriptional co-activator. Embo J 18: 2551-2562, 1999. (Pubitemid 29213286)
24. Mohler PJ, Kreda SM, Boucher RC, Sudol M, Stutts MJ and Milgram SL: Yes-associated protein 65 localizes p62(c-Yes) to the apical compartment of airway epithelia by association with EBP50. J Cell Biol 147: 879-890, 1999.
25. Espanel X and Sudol M: Yes-associated protein and p53-binding protein-2 interact through their WW and SH3 domains. J Biol Chem 276: 14514-14523, 2001.
26. Strano S, Monti O, Pediconi N, et al: The transcriptional coactivator Yes-associated protein drives p73 gene-target specificity in response to DNA Damage. Mol Cell 18: 447-459, 2005. (Pubitemid 40704759)
27. Zhao B, Kim J, Ye X, Lai ZC and Guan KL: Both TEAD-binding and WW domains are required for the growth stimulation and oncogenic transformation activity of yes-associated protein. Cancer Res 69: 1089-1098, 2009.
28. Komuro A, Nagai M, Navin NE and Sudol M: WW domain-containing protein YAP associates with ErbB-4 and acts as a co-transcriptional activator for the carboxyl-terminal fragment of ErbB-4 that translocates to the nucleus. J Biol Chem 278: 33334-33341, 2003. (Pubitemid 37055785)
29. Zaidi SK, Sullivan AJ, Medina R, et al: Tyrosine phosphorylation controls Runx2-mediated subnuclear targeting of YAP to repress transcription. Embo J 23: 790-799, 2004. (Pubitemid 38418746)
30. Chen L, Li X, Wang GL, Wang Y, Zhu YY and Zhu J: Clinicopathological significance of overexpression of TSPAN1, Ki67 and CD34 in gastric carcinoma. Tumori 94: 531-538, 2008.
31. Schipper DL, Wagenmans MJ, Peters WH and Wagener DJ: Significance of cell proliferation measurement in gastric cancer. Eur J Cancer 34: 781-790, 1998. (Pubitemid 28248486)
32. Lehner R, Enomoto T, McGregor JA, Shroyer L, Haugen BR, Pugazhenthi U and Shroyer KR : Correlation of survivin mRNA detection with histologic diagnosis in normal endometrium and endometrial carcinoma. Acta Obstet Gynecol Scand 81: 162-167, 2002. (Pubitemid 34242374)
33. Da CL, Xin Y, Zhao J and Luo XD: Significance and relationship between Yes-associated protein and survivin expression in gastric carcinoma and precancerous lesions. World J Gastroenterol 15: 4055-4061, 2009.
34. Lamerz R: AFP isoforms and their clinical significance (overview). Anticancer Res 17: 2927-2930, 1997.
35. Xu MZ, Yao TJ, Lee NP, et al: Yes-associated protein is an independent prognostic marker in hepatocellular carcinoma. Cancer 115: 4576-4585, 2009.